Australia TGA ARTG recordHerpes simplex virus (HSV) (Human herpesvirus 1 & 2) IVDs
Australia TGA ARTG Registered Device · R-Biopharm Pty Ltd · R-Biopharm AG · Class IIb · Started September 17, 2015
Good Name: R-Biopharm Pty Ltd - Herpes simplex virus (HSV) (Human herpesvirus 1 & 2) IVDs
- Risk Class
- Class IIb
- Product Type
- IVD
- ARTG Category
- IVD
- Start Date
- September 17, 2015
- Effective Date
- September 17, 2015
- Name
- R-Biopharm AG
- Country
- Germany
- Address
- An der neuen Bergstrasse 17, Darmstadt, 64297
Intended to provide information about infection with or exposure to Herpes simplex virus 1 and/or Herpes simplex virus 2
Access comprehensive regulatory information for Herpes simplex virus (HSV) (Human herpesvirus 1 & 2) IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by R-Biopharm Pty Ltd, manufactured by R-Biopharm AG in Germany. The device registration started on September 17, 2015.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.